Laminarin ameliorates hepatic steatosis and upregulates hepatic SMP-30 expression in high-fat-diet-induced NAFLD mice

Key Points

• Hepatic steatosis improves significantly after treatment with laminarin, indicating its protective effects.
• Laminarin treatment results in increased expression of SMP-30, a key protein in liver function.
• Experimental analysis used a high-fat diet-induced NAFLD mouse model, providing insights into dietary impacts.
• Findings suggest laminarin could be a viable intervention for combating NAFLD-related liver damage.